Quality assurance in brachytherapy: the role of the ICRU in achieving uniformity in dose and volume specification for reporting.
A quality assurance programme in brachytherapy implies a general consensus on the method of dose and volume specification for reporting. This in turn implies a consensus on certain definitions of terms and concepts. For several decades, the ICRU (International Commission on Radiation Units and Measurements) has been actively involved in an effort to reach a consensus between different brachytherapy centres worldwide, and to improve uniformity in reporting. The ICRU has prepared two reports containing recommendations for reporting brachytherapy treatments. The first, report #38 published in 1985, deals with intracavitary therapy in gynecology. The second deals with interstitial therapy, and is now in press. A summary of these two ICRU reports is presented here. Some definitions of terms and concepts are first recalled and discussed: Total Reference Air Kerma (TRAK), gross tumor volume (GTV), clinical target volume (CTV), treated volume, mean central dose, dose uniformity parameters, etc. Specific recommendations for reporting interstitial and intracavitary brachytherapy are then presented.
Wambersie
A
A
ICRU Main Commission, Université Catholique de Louvain, Cliniques Universitaires St-Luc, Bruxelles, Belgium.
Chassagne
D
D
Dutreix
A
A
Almond
P
P
Ash
D
D
Burgers
M
M
Bush
M
M
Cohen
M
M
Hanson
W
W
Joslin
C
C
Landberg
T
T
Visser
A
A
Wilson
F
F
D001918:Brachytherapy / Q000592:standards*; D006801:Humans; D011879:Radiotherapy Dosage / Q000592:standards